American Strategic Investment (NYC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Portfolio consists of six office and retail properties in Manhattan totaling approximately 1 million square feet, with 82% occupancy as of June 30, 2025, and a weighted-average remaining lease term of 6.0 years, up from 5.4 years last quarter.
Top 10 tenants account for 77% investment grade or implied investment grade rent, with a 7.5-year average remaining lease term.
Management is actively pursuing lease renewals, tenant retention, and marketing select properties for sale to address liquidity and maximize returns.
The company faces ongoing challenges from the post-pandemic office market, with leasing activity pressured and new leases signed at lower rates.
Two mortgages totaling $149.0 million are in default, with foreclosure litigation initiated on 1140 Avenue of the Americas.
Financial highlights
Q2 2025 revenue was $12.2 million, down from $15.8 million in Q2 2024, mainly due to the sale of Nine Times Square.
GAAP net loss attributable to common stockholders was $41.7 million, improved from $91.9 million in Q2 2024; impairment charges in Q2 2025 totaled $30.6 million.
Adjusted EBITDA was $0.4 million, down from $4.5 million in Q2 2024.
Cash net operating income was $4.2 million, compared to $7.4 million in Q2 2024.
Interest expense increased to $7.9 million in Q2 2025, mainly due to default interest on loans in default.
Outlook and guidance
Management is marketing 123 William Street and 196 Orchard for sale, with proceeds expected to retire debt and reinvest in higher-yielding assets, including diversification outside Manhattan.
Ongoing liquidity constraints are expected, with plans to pay related party fees in shares and sell a performing asset within 12 months.
Cash rent collections remain high at 98% for the six months ended June 30, 2025, but future collections are uncertain.
Capital expenditures for 2025 are expected to be lower than 2024, but may change as needed.
Latest events from American Strategic Investment
- $91.9M net loss on $84.7M impairment, $63.5M sale pending, EBITDA and occupancy up.NYC
Q2 20241 Feb 2026 - Q3 net loss rose on impairments; 9 Times Square sale to cut leverage and boost diversification.NYC
Q3 202414 Jan 2026 - Net loss narrowed in Q4 2024 as asset sales improved leverage and a new CEO was appointed.NYC
Q4 202424 Dec 2025 - Annual meeting to vote on director, auditor, and say-on-pay, with all proposals recommended for approval.NYC
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on director, auditor, and executive pay on May 29, 2025.NYC
Proxy Filing1 Dec 2025 - Revenue and NOI fell, losses widened, but occupancy rose and liquidity risks remain.NYC
Q1 202526 Nov 2025 - Q3 2025 delivered $35.8M net income, stable occupancy, and ongoing liquidity and listing risks.NYC
Q3 202520 Nov 2025